WHAT IS MDT TRIAL
Research Nurse who ensures that any appropriate patients who might benefit from being entered into a clinical trial are discussed.
The following core members of the MDT are required to attend meetings every week or fortnight.Ĭonsultant Haematologists and Specialist Registrars who have instigated investigations to obtain a diagnosis and are responsible for the treatment of patients.Ĭonsultant Radiologists who review and report scans and X-rays to confirm diagnosis and who can advise on further testing, monitoring or management.Ĭonsultant Histopathologists who specialise in blood and bone marrow diseases, who report their findings after examining and testing tissue samples to confirm diagnosis.Ĭonsultant Oncologists who recommend and provide radiotherapy treatment when required.Īdvanced Nurse Practitioners who ensure that every patient has a named Key Worker allocated and contribute to discussion of care of patients based on holistic needs assessment. MDT meetings may be held at your local hospital, or regionally by video conference to share expertise. The MDT will then discuss and recommend the best form of treatment based on local and national guidelines and on each individual patient's circumstances. The MDT comprises specialist doctors and nurses, who meet regularly to establish that every patient's diagnosis is correctly made, based on blood and tissue samples, X-rays and scans. The management of patients with complex disease such as cancer is very much a team approach, and each case is discussed in confidence within a multidisciplinary team (MDT). When a patient is referred for investigations and a diagnosis of cancer is made their care and treatment is the responsibility of a specialist consultant.